190 related articles for article (PubMed ID: 33851647)
21. Microfluidic-Based Detection of AML-Specific Biomarkers Using the Example of Promyelocyte Leukemia.
Emde B; Kreher H; Bäumer N; Bäumer S; Bouwes D; Tickenbrock L
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255664
[TBL] [Abstract][Full Text] [Related]
22. Pathogenetic implication of fusion genes in acute promyelocytic leukemia and their diagnostic utility.
Baba SM; Pandith AA; Shah ZA; Baba RA
Clin Genet; 2019 Jan; 95(1):41-52. PubMed ID: 29700805
[TBL] [Abstract][Full Text] [Related]
23. Microarray, gene sequencing, and reverse transcriptase-polymerase chain reaction analyses of a cryptic PML-RARA translocation.
Koshy J; Qian YW; Bhagwath G; Willis M; Kelley TW; Papenhausen P
Cancer Genet; 2012 Oct; 205(10):537-40. PubMed ID: 22982005
[TBL] [Abstract][Full Text] [Related]
24. RARA fluorescence in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemia.
Lee DS; Lee YS; Kim YR; Han KS; Park KU; She CJ; Kim EC; Park SY; Cho HI
Cancer Genet Cytogenet; 2002 Dec; 139(2):104-8. PubMed ID: 12550769
[TBL] [Abstract][Full Text] [Related]
25. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
[TBL] [Abstract][Full Text] [Related]
26. Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.
King D; Foucar CE; Ma V; Benitez L; Perissinotti AJ; Marini BL; Robinson D; Bhave RR; Bixby D
Cancer Genet; 2021 Nov; 258-259():57-60. PubMed ID: 34534739
[TBL] [Abstract][Full Text] [Related]
27. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
[TBL] [Abstract][Full Text] [Related]
28. No prognostic significance of normalized copy number of PML-RARA transcript at diagnosis in patients with acute promyelocytic leukemia.
Rasekh EO; Elsayed GM; Fathy S
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):119-125. PubMed ID: 32735792
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetically cryptic and fish negative PML/RARA rearrangement in acute promyelocytic leukemia detected by RT-PCR.
Avgerinou G; Katsibardi Κ; Filippidou M; Tzanoudaki M; Papadhimitriou SI; Kattamis A
Leuk Lymphoma; 2020 Dec; 61(14):3526-3528. PubMed ID: 32909480
[No Abstract] [Full Text] [Related]
30. Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
Greenfield G; Michail O; Merron B; McGimpsey J; Catherwood M; McMullin MF
Br J Haematol; 2019 Jul; 186(1):155-157. PubMed ID: 30585303
[No Abstract] [Full Text] [Related]
31. Tetraploid/near-tetraploid acute promyelocytic leukaemia with double (15;17) translocation.
Tay Za K; Jackson N; Chin EFM
Malays J Pathol; 2020 Apr; 42(1):127-130. PubMed ID: 32342942
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge.
Mohebnasab M; Li P; Hong B; Dunlap J; Traer E; Fan G; Press RD; Moore SR; Xie W
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685882
[TBL] [Abstract][Full Text] [Related]
33. A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: a comparative study of RT-PCR cytogenetics, and fluorescence In situ hybridization.
Rennert H; Golde T; Wilson RB; Spitalnik SL; Van Deerlin VM; Leonard DG
Mol Diagn; 1999 Sep; 4(3):195-209. PubMed ID: 10553020
[TBL] [Abstract][Full Text] [Related]
34. Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literature.
Tang Y; Wang Y; Hu L; Meng F; Xu D; Wan K; Huang L; Li C; Zhou J
Int J Clin Exp Pathol; 2015; 8(11):15294-300. PubMed ID: 26823883
[TBL] [Abstract][Full Text] [Related]
35. [Pilot study of PML/RAR alpha fusion by fluorescence in situ hybridization (FISH)method in acute promyelocyte leukemia].
Legües ME; Franco G; Bertin P
Rev Med Chil; 2002 Jul; 130(7):737-44. PubMed ID: 12235897
[TBL] [Abstract][Full Text] [Related]
36. Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients.
Dimov ND; Medeiros LJ; Kantarjian HM; Cortes JE; Chang KS; Bueso-Ramos CE; Ravandi F
Cancer; 2010 Jan; 116(2):369-76. PubMed ID: 19950129
[TBL] [Abstract][Full Text] [Related]
37. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
García-Casado Z; Cervera J; Valencia A; Pajuelo JC; Mena-Duran AV; Barragán E; Bolufer P; Sanz MA
Cancer Genet Cytogenet; 2006 Jul; 168(1):73-6. PubMed ID: 16772124
[TBL] [Abstract][Full Text] [Related]
38. Utility and impact of early t(15;17) identification by Fluorescence In Situ Hybridization (FISH) in clinical decision making for patients in Acute Promyelocytic Leukemia (APL).
Kolhe R; Mangaonkar A; Mansour J; Clemmons A; Shaw J; Dupont B; Walczak L; Mondal A; Rojiani A; Jillella A; Kota V
Int J Lab Hematol; 2015 Aug; 37(4):515-20. PubMed ID: 25639817
[TBL] [Abstract][Full Text] [Related]
39. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia.
Abe S; Ishikawa I; Harigae H; Sugawara T
Cancer Genet Cytogenet; 2008 Jul; 184(1):44-7. PubMed ID: 18558288
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia.
Schad CR; Hanson CA; Paietta E; Casper J; Jalal SM; Dewald GW
Mayo Clin Proc; 1994 Nov; 69(11):1047-53. PubMed ID: 7967757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
